Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Poster Presentations

Diabetes, Obesity and Metabolism 3

Previous section
Adrenal and Neuroendocrine Tumours 3
Table of contents
Next section
Environment, Society and Governance

ea0063p882 | Diabetes, Obesity and Metabolism 3

Vitamin D receptor gene polymorphisms and lipid profile in different vitamin D status women

ea0063p883 | Diabetes, Obesity and Metabolism 3

Impact of the overweight and fatty liver in chronic hepatitis B treatment

ea0063p884 | Diabetes, Obesity and Metabolism 3

Development of diabetes after pancreatic resection

ea0063p885 | Diabetes, Obesity and Metabolism 3

Threatening hypertriglyceridemia during pregnancy revealing laminopathy and genetic susceptibility in a patient with type 1 diabetes

ea0063p886 | Diabetes, Obesity and Metabolism 3

Perforating necrobiosis lipoidica: a new case report

ea0063p887 | Diabetes, Obesity and Metabolism 3

Management of hyperglycaemia risk in patients on medium or long-term glucocorticoid treatment: a retrospective pilot study

ea0063p888 | Diabetes, Obesity and Metabolism 3

Maturity onset diabetes of the young type 5 – report of one phenotype

ea0063p889 | Diabetes, Obesity and Metabolism 3

Radiation-induced loss of glycemic control in a patient with refractory lymphoma

ea0063p890 | Diabetes, Obesity and Metabolism 3

Auto immune hypoglycemia in individuals with type 1 diabetes, from a patient case report

ea0063p891 | Diabetes, Obesity and Metabolism 3

Scleredema adultorum of buschke: a case report

ea0063p892 | Diabetes, Obesity and Metabolism 3

An investigation into the relationship between plasma concentrations of cortisol, testosterone, blood pressure and blood glucose levels in diabetic hypersensitive cardiovascular patients

ea0063p893 | Diabetes, Obesity and Metabolism 3

Necrosis of the nasal pyramid in a type 1 diabetic after prolonged intubation: in the light of a case

ea0063p894 | Diabetes, Obesity and Metabolism 3

Revelation modalities of latent autoimmune diabetes of adults

ea0063p895 | Diabetes, Obesity and Metabolism 3

Neuroendocrine neoplasia and obesity

ea0063p896 | Diabetes, Obesity and Metabolism 3

NME7 gene is associated with the shape of glucose curves during oral glucose tolerance test

ea0063p897 | Diabetes, Obesity and Metabolism 3

From the glucocentric model to new opportunitiesmetabolic control

ea0063p898 | Diabetes, Obesity and Metabolism 3

Does diabetes expose to multidrug-resistant urinary tract infections?

ea0063p899 | Diabetes, Obesity and Metabolism 3

Impact of hypomagnesemia in type 2 diabetes mellitus

ea0063p900 | Diabetes, Obesity and Metabolism 3

The results of diabetic foot syndrome screening among rural patients with diabetes in Uzbekistan

ea0063p901 | Diabetes, Obesity and Metabolism 3

The role of ‘Diabetic Foot’ rooms in the organization of specialised help to patient with diabetic foot syndrome in Uzbekistan

ea0063p902 | Diabetes, Obesity and Metabolism 3

Corticoid induced diabetes: where? when?

ea0063p903 | Diabetes, Obesity and Metabolism 3

Short term metabolic outcome following bariatric surgery; A single center experience from Asia

ea0063p904 | Diabetes, Obesity and Metabolism 3

Case report: Bullous pemphigoid in a patient with type 2 Diabetes on treatment with linagliptin

ea0063p905 | Diabetes, Obesity and Metabolism 3

Epidemiological research on diabetic rethynopatia prevalence in newly diagnosed people with type 2 diabetes in Uzbekistan

ea0063p906 | Diabetes, Obesity and Metabolism 3

Gestational Diabetes in Early Pregnancy – what does fasting glucose tell us?

ea0063p907 | Diabetes, Obesity and Metabolism 3

Weight change of a population of diabetic patients previously educated and having fasted the month of Ramadan

ea0063p908 | Diabetes, Obesity and Metabolism 3

Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphighoid

ea0063p909 | Diabetes, Obesity and Metabolism 3

Circulating microRNAs expression profile in individuals with obesity compared to healthy controls

ea0063p910 | Diabetes, Obesity and Metabolism 3

Gestational Diabetes: what to say about body mass index and outcomes? The influence of prepregnancy body mass index on obstetric and neonatal outcomes of women with gestational diabetes

ea0063p911 | Diabetes, Obesity and Metabolism 3

Assessement of magnesemic status in patients with metabolic syndrome

ea0063p912 | Diabetes, Obesity and Metabolism 3

1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) and lipid accumulation in liver cells: A role for epigenetic mechanisms?

ea0063p913 | Diabetes, Obesity and Metabolism 3

Blood pressure objectives in diabetic patients: about 588 cases

ea0063p914 | Diabetes, Obesity and Metabolism 3

miRNAs-target genes, miRNA-lncRNA, and miRNA-small molecules interactions involved in metabolic diseases

ea0063p915 | Diabetes, Obesity and Metabolism 3

Profile of patients using continuous subcutaneous insulin infusion in portugal

ea0063p916 | Diabetes, Obesity and Metabolism 3

Genetic variants of TCF7L2 gene in Lithuanian women population with previously diagnosed Gestational Diabetes Mellitus compared to General Population

ea0063p917 | Diabetes, Obesity and Metabolism 3

Angiotensin-converting enzyme (ACE) gene I/D polymorphism and angiotensin II type 1 receptor (AGTR1) gene A1166C polymorphism and diabetic kidney disease

ea0063p918 | Diabetes, Obesity and Metabolism 3

Risk factors for diabetic retinopathy: About 454 patients

ea0063p919 | Diabetes, Obesity and Metabolism 3

Diabetes Eruditus: Characteristics of type 1 diabetes of long duration

ea0063p920 | Diabetes, Obesity and Metabolism 3

The Soft tissue infections in diabetic patients

ea0063p921 | Diabetes, Obesity and Metabolism 3

Diabetic foot education: patient satisfaction (about 151 cases)

ea0063p922 | Diabetes, Obesity and Metabolism 3

The cardio-metabolic profile of elderly patient with diabetes mellitus type 2 (about 300 case)

ea0063p923 | Diabetes, Obesity and Metabolism 3

Flash glucose monitoring system in children under 18 years old with diabetes mellitus type 1 in the southern hospital area of Granada: preliminary results

ea0063p924 | Diabetes, Obesity and Metabolism 3

Candidiasis infections in the diabetic About 307 cases

ea0063p925 | Diabetes, Obesity and Metabolism 3

The diabetes mellitus type 2 in elderly patients: comorbidities and polymedication (about 300 cases)

ea0063p926 | Diabetes, Obesity and Metabolism 3

Factors influencing the practice of physical activity in youth with type 1 diabetes mellitus

ea0063p927 | Diabetes, Obesity and Metabolism 3

Reasons for consultation in diabetological emergencies

ea0063p928 | Diabetes, Obesity and Metabolism 3

Assessment of therapeutic education in diabetes patients on insulin at the pharmacy

ea0063p929 | Diabetes, Obesity and Metabolism 3

Idiopathic versus autoimmune type 1 diabetes – long-term differences

ea0063p930 | Diabetes, Obesity and Metabolism 3

Whole body cryotherapy effect on weight gain and metabolic parameters of metabolic and type 2 diabetic patients

ea0063p931 | Diabetes, Obesity and Metabolism 3

Sexual dimorphism in the mechanisms for insulin resistance

ea0063p932 | Diabetes, Obesity and Metabolism 3

Glucosuric drugs + immune checkpoint inhibitors: A recipe for diabetic ketoacidosis?

ea0063p933 | Diabetes, Obesity and Metabolism 3

The Oral status of elderly patient with diabetes mellitus type 2: a real factor of risk of malnutrition (about 300 cases)

ea0063p934 | Diabetes, Obesity and Metabolism 3

Glycemic equilibrium of cancer patients with diabetes

ea0063p935 | Diabetes, Obesity and Metabolism 3

Management of diabetic patients with cancer

ea0063p936 | Diabetes, Obesity and Metabolism 3

Let use results of foot examination for guiding diabetes mellitus therapy

ea0063p937 | Diabetes, Obesity and Metabolism 3

MicroRNA-26a, microRNA-33a, and microRNA-33b in patients with obesity: association with coronary artery disease

ea0063p938 | Diabetes, Obesity and Metabolism 3

Transition of young adults with type 1 diabetes

ea0063p939 | Diabetes, Obesity and Metabolism 3

Prevalence and predictive factors of advanced fibrosis in type 2 diabetic patient in a majoritally abstinent population of alcohol

ea0063p940 | Diabetes, Obesity and Metabolism 3

The metabolic profile of diabetic patients during the month of Ramadan

ea0063p941 | Diabetes, Obesity and Metabolism 3

Increased serum resistin levels in metabolically unhealthy compared to metabolically healthy obese individuals; correlation with circulating white blood cell subpopulations

ea0063p942 | Diabetes, Obesity and Metabolism 3

Discharge in the diabetic foot: means, indications and observance: about 102 cases (preliminary results)

ea0063p943 | Diabetes, Obesity and Metabolism 3

Drug interactions in diabetic patients

ea0063p944 | Diabetes, Obesity and Metabolism 3

The impact of cigarette smoking on metabolic syndrome in diabetic patients type 2: about 322 cases

ea0063p945 | Diabetes, Obesity and Metabolism 3

The association between glycemic control and hip fracture risk – a retrospective Cohort study

ea0063p946 | Diabetes, Obesity and Metabolism 3

Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

ea0063p947 | Diabetes, Obesity and Metabolism 3

Autoimmune diabetes mellitus versus idiopathic: differences at diagnosis

ea0063p948 | Diabetes, Obesity and Metabolism 3

The relationship of vitamin D status, adherence to the Mediterranean diet and physical activity in obese children and adolescents

ea0063p949 | Diabetes, Obesity and Metabolism 3

Detection of metabolic hepatic steatosis in type 2 diabetic patient: about 281 cases

ea0063p950 | Diabetes, Obesity and Metabolism 3

Relative fat mass correlates better than BMI with total body fat – experience of an obesity clinic

ea0063p951 | Diabetes, Obesity and Metabolism 3

Characterisation of Turner syndrome glucose homeostasis; autoimmunity, adiposity and insulin sensitivity

ea0063p952 | Diabetes, Obesity and Metabolism 3

Autotaxin level in patients with type 2 diabetes mellitus or cardiovascular disease

ea0063p953 | Diabetes, Obesity and Metabolism 3

Hepatic steatosis and cardiovascular risk in diabetic patient type 2

ea0063p954 | Diabetes, Obesity and Metabolism 3

Doege-potter syndrome in patients with malignant extrapleural solitary fibrous tumor: a single center experience

ea0063p955 | Diabetes, Obesity and Metabolism 3

Transgenic production of endogenous n-3 PUFA levels compared to fish oil intake differentially improve obesity-related metabolic disorders: role of the gut microbiota

ea0063p956 | Diabetes, Obesity and Metabolism 3

Clinical particularities of acute pancreatitis in diabetic patients: about 60 cases

ea0063p957 | Diabetes, Obesity and Metabolism 3

Impact of bariatric techniques in the long-term weight loss

ea0063p958 | Diabetes, Obesity and Metabolism 3

Ramadan fasting effects on the clinical and metabolic parameters of a previously educated population of diabetic, hypertensive and dyslipidemic patients

ea0063p959 | Diabetes, Obesity and Metabolism 3

Different pattern of clinical presentation between newly onset ketone prone diabetes and type 1 diabetes in a tertiary hospital

ea0063p960 | Diabetes, Obesity and Metabolism 3

Prevalence of postprandial hyperinsulinemic hypoglycaemia in a random population after primary Roux-en-Y gastric bypass during a mixed meal tolerance test

ea0063p961 | Diabetes, Obesity and Metabolism 3

The prevalence of impaired cognitive function and depression in patients with type 2 diabetes mellitus and severe insulin resistance

ea0063p962 | Diabetes, Obesity and Metabolism 3

Gender differences in patients with coronary heart disease and diabetes: A multicentric retrospective study

ea0063p963 | Diabetes, Obesity and Metabolism 3

Delayed menarche, oligomenorrhea and hyperandrogenism in type 1 diabetes mellitus

ea0063p964 | Diabetes, Obesity and Metabolism 3

‘Development of new dietetic approach for obese and overweight adults without metabolic factors for cardiovascular disease: preliminary results’

ea0063p965 | Diabetes, Obesity and Metabolism 3

Prediabetes: expectations and attitudes

ea0063p966 | Diabetes, Obesity and Metabolism 3

The level of the vitamin D, osteoprotegerin and metabolic status in children with obesity

ea0063p967 | Diabetes, Obesity and Metabolism 3

Assessment of the educational level of diabetics regarding their foot

ea0063p968 | Diabetes, Obesity and Metabolism 3

Diabetic foot: Assessment of the diabetic patient’s knowledge before and after a day of education

ea0063p969 | Diabetes, Obesity and Metabolism 3

Knowledge and practices of diabetic patients during Ramadan

ea0063p970 | Diabetes, Obesity and Metabolism 3

Late diarrhea in diabetic patients under metformin: An undesirable effect of the molecule appearing late?

ea0063p971 | Diabetes, Obesity and Metabolism 3

Are fast insulin analogues fast enough? Switching to faster aspart may reduce glycemic variability and the risk of hypoglycemia in type 1 diabetic patients on sensor-augmented insulin pump therapy

ea0063p972 | Diabetes, Obesity and Metabolism 3

The effects of metformin monotherapy on lipid profile in patients with type 2 diabetes mellitus

ea0063p973 | Diabetes, Obesity and Metabolism 3

Effects of diabetes mellitus on female sexual function

ea0063p974 | Diabetes, Obesity and Metabolism 3

Canagliflozin: Ankle-Brachial index (ABPI) and risk of amputations

ea0063p975 | Diabetes, Obesity and Metabolism 3

Impact of diabetes on professional activity

ea0063p976 | Diabetes, Obesity and Metabolism 3

Clinical characteristics of human POMC, PCSK1, and LEPR deficiencies

ea0063p977 | Diabetes, Obesity and Metabolism 3

Association between physical inactivity and socioeconomic factors and lifestyle among Tunisian adolescents

ea0063p978 | Diabetes, Obesity and Metabolism 3

Doctor, is it cancer? A rock-hard breast lump in an anxious type 1 diabetic male-to-female transgender patient

ea0063p979 | Diabetes, Obesity and Metabolism 3

Hypoglycemia: a major problem in diabetics

ea0063p980 | Diabetes, Obesity and Metabolism 3

The influence of the prediabetes phenotype on the efficacy of lifestyle interventions to improve glycemia, insulin resistance and postprandial hyperinsulinaemia

ea0063p981 | Diabetes, Obesity and Metabolism 3

Effectiveness and tolerance of liraglutide and bupropión/naltrexone: clinical experience

ea0063p982 | Diabetes, Obesity and Metabolism 3

The incidence of pancreatic cancer in diabetic patients

ea0063p983 | Diabetes, Obesity and Metabolism 3

GLP-1 Agonist as an effective add-on basal-bolus therapy in type 2 diabetic patients

ea0063p984 | Diabetes, Obesity and Metabolism 3

The relation between HbA1c, glucose management indicator and average glucose parameters

ea0063p985 | Diabetes, Obesity and Metabolism 3

An overview of urinary tract infection in diabetic patients

ea0063p986 | Diabetes, Obesity and Metabolism 3

Weight loss in PCOS - benefits of Metformin and Liraglutide - a single institution experience

ea0063p987 | Diabetes, Obesity and Metabolism 3

Epidemiological, clinical and biochemical characteristics of metabolic syndrome in adults living in South of Tunisia

ea0063p988 | Diabetes, Obesity and Metabolism 3

Effect of high protein diet over caloric expenditure and thermogenesis in individuals with obesity

ea0063p989 | Diabetes, Obesity and Metabolism 3

Metformin and Vitamin B12 deficiency: evaluation of vitamin B12, homocysteine and methylmalonic acid levels in type 2 diabetics

ea0063p990 | Diabetes, Obesity and Metabolism 3

What is the factor that most influences perinatal outcomes in pregnant women with Gestational Diabetes Mellitus: Country of origin or previous Gestational Diabetes?

ea0063p991 | Diabetes, Obesity and Metabolism 3

Neuroimaging in the diagnosis of neuroplasticity in patients with diabetes mellitus

ea0063p992 | Diabetes, Obesity and Metabolism 3

IN-FOCUS France: an epidemiological survey on severe hypertriglyceridaemiae assessing the comparative burden of illness of familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS)

ea0063p993 | Diabetes, Obesity and Metabolism 3

Abstract unavailable

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more